Biohaven is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas. They are guided by science and aim to address unmet medical needs, particularly in the field of neurological diseases.
Focus Areas
Notable Investments
